{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:34:46Z","timestamp":1790102086365,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["16 019\/0000759"],"award-info":[{"award-number":["16 019\/0000759"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12I0317N"],"award-info":[{"award-number":["12I0317N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1136417N"],"award-info":[{"award-number":["1136417N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["TT- ZAPBOF 33049"],"award-info":[{"award-number":["TT- ZAPBOF 33049"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["DOCPRO4 33265"],"award-info":[{"award-number":["DOCPRO4 33265"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["TOP-BOF 35017"],"award-info":[{"award-number":["TOP-BOF 35017"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ijpddr.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T02:13:25Z","timestamp":1588299205000},"page":"16-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection"],"prefix":"10.1016","volume":"13","author":[{"given":"Lieselotte","family":"Van Bockstal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Bult\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hendrickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovana","family":"Sadlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Volf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-3202","authenticated-orcid":false,"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2020.04.004_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2020.04.004_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41579-019-0238-x","article-title":"Protozoan persister-like cells and drug treatment failure","volume":"17","author":"Barrett","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ijpara.2007.04.003","article-title":"Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies","volume":"37","author":"Bates","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib4","article-title":"Natural resistance of Leishmania infantum to miltefosine contributes to the low efficacy in the treatment of visceral leishmaniasis in Brazil","author":"Brambilla Carnielli Trindade","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib5","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1128\/AAC.00587-08","article-title":"Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement","volume":"52","author":"Castanys-Mu\u00f1oz","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"Leishmania resistance to miltefosine associated with genetic marker","volume":"18","author":"Cojean","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib7","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.ijpddr.2020.04.004_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jac\/dky450","article-title":"Miltefosine enhances the fitness of a non-virulent drug-resistant Leishmania infantum strain","volume":"74","author":"Eberhardt","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007726","article-title":"Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India","volume":"13","author":"Goyal","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib10","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/jac\/dkw096","article-title":"Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum","volume":"71","author":"Hendrickx","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib11","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00436-014-3835-7","article-title":"Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum","volume":"113","author":"Hendrickx","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib12","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/AAC.00707-15","article-title":"In vivo selection of paromomycin and miltefosine resistance in Leishmania donovani and L. infantum in a Syrian hamster model","volume":"59","author":"Hendrickx","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ijpddr.2020.04.004_bib13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/jac\/dkz517","article-title":"Transmission potential of paromomycin-resistant Leishmania infantum and Leishmania donovani","volume":"75","author":"Hendrickx","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-020-3972-z","article-title":"Phenotypic adaptations of Leishmania donovani to recurrent miltefosine exposure and impact on sand fly infection","volume":"13","author":"Hendrickx","year":"2020","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2020.04.004_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005620","article-title":"Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum","volume":"11","author":"Hendrickx","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1","key":"10.1016\/j.ijpddr.2020.04.004_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pt.2019.10.005","article-title":"New strategies and biomarkers for the control of visceral leishmaniasis","volume":"36","author":"Ibarra-Meneses","year":"2020","journal-title":"Trends Parasitol."},{"issue":"2","key":"10.1016\/j.ijpddr.2020.04.004_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/jac\/dkx407","article-title":"Miltefosine-resistant Leishmania infantum strains with an impaired MT\/ROS3 transporter complex retain amphotericin B susceptibility","volume":"73","author":"Mondelaers","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154101","article-title":"Genomic and molecular characterization of miltefosine resistance in Leishmania infantum strains with either natural or acquired resistance through experimental selection of intracellular amastigotes","volume":"11","author":"Mondelaers","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2020.04.004_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02507-18","article-title":"Systematic review of host-mediated activity of miltefosine in leishmaniasis through immunomodulation","volume":"63","author":"Pali\u0107","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib20","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","article-title":"Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites","volume":"281","author":"Perez-Victoria","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use","volume":"9","author":"Perez-Victoria","year":"2006","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ijpddr.2020.04.004_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00611-13","article-title":"Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain","volume":"4","author":"Rai","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2020.04.004_bib24","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib25","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1128\/AAC.02406-13","article-title":"Transmission potential of antimony-resistant Leishmania field isolates","volume":"58","author":"Seblova","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib26","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/mmi.13291","article-title":"In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization","volume":"99","author":"Shaw","year":"2016","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13071-017-1969-z","article-title":"Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India","volume":"10","author":"Srivastava","year":"2017","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2020.04.004_bib28","volume":"vol 45","author":"Stauber","year":"1958"},{"key":"10.1016\/j.ijpddr.2020.04.004_bib29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/591972","article-title":"New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine","volume":"47","author":"Sundar","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003948","article-title":"Fitness and phenotypic characterization of miltefosine-resistant Leishmania major","volume":"9","author":"Turner","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib31","first-page":"1","article-title":"Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis","volume":"11","author":"Van Bockstal","year":"2019","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023120","article-title":"Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden","volume":"6","author":"Vanaerschot","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2020.04.004_bib33","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/1040841X.2012.716818","article-title":"Drug-resistant microorganisms with a higher fitness\u2013can medicines boost pathogens?","volume":"39","author":"Vanaerschot","year":"2013","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1574-6976.12032","article-title":"Drug resistance in vector borne parasites: multiple actors and scenarios for an evolutionary arms race","volume":"38","author":"Vanaerschot","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2020.04.004_bib35","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences","volume":"53","author":"Vermeersch","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 1","key":"10.1016\/j.ijpddr.2020.04.004_bib36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1948-7134.2011.00106.x","article-title":"Establishment and maintenance of sand fly colonies","volume":"36","author":"Volf","year":"2011","journal-title":"J. Vector Ecol."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:39:56Z","timestamp":1778845196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320720300099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":36,"alternative-id":["S2211320720300099"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.04.004","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}